BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro (reuters.com)

Font size: Decrease font Enlarge font

Mon, 10 Feb 2014 16:41:32 GMT – Feb 10 (Reuters) – Vectura Group PLC : * Norwegian regulatory authority confirm approval of airflusal forspiro * Treatment is new inhaler for patients with asthma and chronic obstructive

Full Story BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro

Tags: , , , , ,

Add to:


More Health News
REFILE-In U.S. Ebola fight, no two quarantines are quite the same » (reuters.com)

Thu, 30 Oct 2014 12:29:13 GMT – (Refiling to correct typographical error in first paragraph)

UPDATE 1-Coloplast profit hit by provision for U.S. lawsuits » (reuters.com)

Thu, 30 Oct 2014 12:29:55 GMT – * Sees Sales up 9 pct in 2014/15 despite price pressures (Adds details, CEO comment)

Novo Nordisk more cautious on timing of U.S. Tresiba launch » (reuters.com)

Thu, 30 Oct 2014 11:55:04 GMT – COPENHAGEN, Oct 30 (Reuters) – Novo Nordisk is more cautious in its assessment of when it would launch its Tresiba diabetes drug in the United States, a critical growth driver for the future, according to statements it made in its quarterly report.

BRIEF-Cortendo announces Healthcap Leads $11 mln Private Placement » (reuters.com)

Thu, 30 Oct 2014 12:03:52 GMT – * Announces Healthcap Leads $11 million (73.4 million Norwegian crowns) Private Placement

UPDATE 1-India's universal healthcare rollout to cost $26 bln: official » (reuters.com)

Thu, 30 Oct 2014 10:21:14 GMT – * Programme could face funding challenges: official (Writes through, adding quotes, experts, context)

BRIEF-Novacyt Group reports H1 pro forma sales of 3.76 mln euros » (reuters.com)

Thu, 30 Oct 2014 10:27:23 GMT – * Following acquisition of Lab21 pro forma sales of Novacyt Group are 3.76 million euros in H1 compared to sales of 582,000 euros in prior year

UPDATE 1-Cigna says third-quarter revenue increased with customer growth » (reuters.com)

Thu, 30 Oct 2014 10:53:44 GMT – Oct 30 (Reuters) – Cigna Corp on Thursday reported a higher-than-expected third-quarter profit as it signed up more medical customers and collected more insurance premiums and administrative fees.

Coloplast operating profit in line, proposes dividend » (reuters.com)

Thu, 30 Oct 2014 10:56:41 GMT – COPENHAGEN, Oct 30 (Reuters) – Danish healthcare products maker Coloplast reported a fourth-quarter operating profit in line with expectations and announced fresh dividend payments.

Bayer says animal health unit large enough » (reuters.com)

Thu, 30 Oct 2014 10:13:04 GMT – FRANKFURT, Oct 30 (Reuters) – Bayer sought to dampen expectations that any proceeds from a separate listing of its plastics unit would be used for takeover deals to bolster its animal health activities.

Cigna says third-quarter revenue increased with customer growth » (reuters.com)

Thu, 30 Oct 2014 10:15:54 GMT – Oct 30 (Reuters) – Cigna Corp on Thursday said that third-quarter revenue grew as it signed up more medical customers and it collected more insurance premiums and administrative fees, but third-quarter profit fell.